Oral Solid Dosage Pharmaceutical Formulation Market: By Product Type (Tablets, Lozenges, Capsules), By Drug Release Mechanism (Sustained Release, Extended Release, Instant Release, Chewable Tablets, Effervescent Tablets, Enteric Release), By Disease Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies), and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Oral Solid Dosage Pharmaceutical Formulation Market was valued at USD 493.3 billion in 2022 and is poised to grow at a CAGR of 6.6% from 2023-2029. Oral solid dosage pharmaceutical formulation are most widely used dosage forms. They are easy to manufacture and transport due to their increased chemical and physical stability. Oral Solid Dosage Pharmaceutical Formulation Market are cost effective when compared with the other kind of dosage forms. These can be formulated in various flavors in order to mask the unpleasant taste of the formulation and increase the patient compliance. The technological advancements are enabling the manufacturers to formulate new drugs such as sustained release dosage forms which minimize the frequent administration of the drug. The most often utilised medications to treat various medical problems are oral solid dose forms. In comparison to other dosage forms, oral solid dosage forms are both cost-effective and simple to manufacture. They provide manufacturers with numerous advantages, including trouble-free packaging and transportation, as well as greater chemical and physical stability. Patients can benefit from oral solids as well. Patients frequently choose oral solid dosage forms because of the inherent advantages in dosage administration and the absence of the need for dose measurement. In order to improve patient compliance, they can be made in a variety of flavours and dose formats. Few APIs, for example, have a disagreeable taste, thus they are made in the form of effervescent tablets to ensure patient acceptability and compliance.

 

Oral Solid Dosage Pharmaceutical Formulation Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.6%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Oral Solid Dosage Pharmaceutical Formulation Market Dynamics

Market players are majorly focused on oral solid dosage forms due to convenience and safe way of administration. Increased sedentary and fast paced lifestyle is leading to adopt lifestyle related diseases such as obesity, diabetes. The manufacturers are targeting the population in developing countries in order to enhance the market. A significant boost is observed in the Asia Pacific region owing to increased population. Moreover, the generic manufacturers are playing a major role in the growth of the oral solid dosage pharmaceutical formulation market by introducing generic drugs in the local market. However, the high regulatory requirement is expected to hamper the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Oral Solid Dosage Pharmaceutical Formulation Market Segmentation

By Type
  • Tablets
  • Lozenges
  • Capsules
By Drug Release
  • Sustained Release
  • Extended Release
  • Instant Release
  • Chewable Tablets
  • Effervescent Tablets
  • Enteric Release
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Frequently Asked Questions

The oral solid dosage pharmaceutical formulation market size was valued at USD 493.3 billion in 2022

Asia Pacific is the fastest-growing for oral solid dosage pharmaceutical formulation market

The oral solid dosage pharmaceutical formulation market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

1.Executive Summary
2.Global Oral Solid Dosage Pharmaceutical Formulation Market Introduction 
2.1.Global Oral Solid Dosage Pharmaceutical Formulation Market  - Taxonomy
2.2.Global Oral Solid Dosage Pharmaceutical Formulation Market  - Definitions
2.2.1.Type 
2.2.2.Drug Release
2.2.3.Distribution Channel
2.2.4.Region
3.Global Oral Solid Dosage Pharmaceutical Formulation Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Oral Solid Dosage Pharmaceutical Formulation Market  By Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Tablets
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Lozenges
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Capsules
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Oral Solid Dosage Pharmaceutical Formulation Market  By Drug Release, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Sustained Release
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Extended Release
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Instant Release
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Chewable Tablets
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Effervescent Tablets
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Enteric Release
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Oral Solid Dosage Pharmaceutical Formulation Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Retail Pharmacies
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Drug Stores
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Online Pharmacies
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Oral Solid Dosage Pharmaceutical Formulation Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Oral Solid Dosage Pharmaceutical Formulation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Type  Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Tablets
9.1.2.Lozenges
9.1.3.Capsules
9.2.  Drug Release Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Sustained Release
9.2.2.Extended Release
9.2.3.Instant Release
9.2.4.Chewable Tablets
9.2.5.Effervescent Tablets
9.2.6.Enteric Release
9.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospital Pharmacies
9.3.2.Retail Pharmacies
9.3.3.Drug Stores
9.3.4.Online Pharmacies
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Oral Solid Dosage Pharmaceutical Formulation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Tablets
10.1.2.Lozenges
10.1.3.Capsules
10.2.  Drug Release Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Sustained Release
10.2.2.Extended Release
10.2.3.Instant Release
10.2.4.Chewable Tablets
10.2.5.Effervescent Tablets
10.2.6.Enteric Release
10.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Retail Pharmacies
10.3.3.Drug Stores
10.3.4.Online Pharmacies
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
10.4.7.
11.Asia Pacific (APAC) Oral Solid Dosage Pharmaceutical Formulation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Tablets
11.1.2.Lozenges
11.1.3.Capsules
11.2.  Drug Release Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Sustained Release
11.2.2.Extended Release
11.2.3.Instant Release
11.2.4.Chewable Tablets
11.2.5.Effervescent Tablets
11.2.6.Enteric Release
11.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Retail Pharmacies
11.3.3.Drug Stores
11.3.4.Online Pharmacies
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Oral Solid Dosage Pharmaceutical Formulation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Tablets
12.1.2.Lozenges
12.1.3.Capsules
12.2.  Drug Release Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Sustained Release
12.2.2.Extended Release
12.2.3.Instant Release
12.2.4.Chewable Tablets
12.2.5.Effervescent Tablets
12.2.6.Enteric Release
12.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Retail Pharmacies
12.3.3.Drug Stores
12.3.4.Online Pharmacies
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Oral Solid Dosage Pharmaceutical Formulation Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Tablets
13.1.2.Lozenges
13.1.3.Capsules
13.2.  Drug Release Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Sustained Release
13.2.2.Extended Release
13.2.3.Instant Release
13.2.4.Chewable Tablets
13.2.5.Effervescent Tablets
13.2.6.Enteric Release
13.3.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Retail Pharmacies
13.3.3.Drug Stores
13.3.4.Online Pharmacies
13.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.AstraZeneca Plc. (UK)
14.2.2.Bristol-Myers Squibb Company (U.S)
14.2.3.Novartis AG (Switzerland)
14.2.4.Pfizer Inc. (U.S)
14.2.5.AbbVie Inc. (U.S)
14.2.6.Boehringer Ingelheim GmbH (Germany)
14.2.7.Johnson & Johnson (U.S)
15. Research Methodology 
16. Appendix and Abbreviations 
  • AstraZeneca Plc. (UK)
  • Bristol-Myers Squibb Company (U.S)
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S)
  • AbbVie Inc. (U.S)
  • Boehringer Ingelheim GmbH (Germany)
  • Johnson & Johnson (U.S)
  • Merck & Co. Inc. (U.S)
  • Gilead Sciences (U.S)

Adjacent Markets